OUR PIPELINE

Guided by Foresight, our proprietary functional genomics platform, we are creating a pipeline of precision oncology treatments by finding and matching the right therapies to the right patients with the hardest to treat cancers.

JOIN US IN GROWING OUR PIPELINE

The Foresight platform enables a repeatable approach to building the pipeline. We continuously identify and in-license new clinic-ready assets that have the potential to reach unaddressed patient populations with precision medicines.

We mainly focus on compounds that have passed Phase 1 trials and proved safe, for which the main challenge is to pinpoint which patient populations they will benefit most. We also consider pre-IND compounds where the biology is well understood and clinical trials are within sight.

We accommodate a wide range of partnering structures, with a focus on in-licensing compounds. To discuss a potential collaboration, please contact our business development team at:
partner@fore.bio